DHPS and melanoma: In conclusion, this study has innovatively identified DHPS‐mediated m6A methylation modification in melanoma and obtained a novel DHPS allosteric inhibitor, GL‐1, which had high efficiency, low toxicity, and good bioavailability in vivo and in vitro.